These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25975904)

  • 1. [Guideline for testing of estrogen and progesterone receptors in breast cancer].
    Guideline Recommendations for Immunohistochemistry Detection in Breast Cancer Group
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):237-9. PubMed ID: 25975904
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibodies in the immunohistochemical detection of estrogen and progesterone receptor status in breast carcinoma].
    Shui R; Yang W
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):229-31. PubMed ID: 25975902
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
    Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunohistochemical quantification of steroid receptors and other prognosis factors in human breast cancer patients.
    Fritz P; Tuczek HV; Offinger B; Schwarzmann P; Schieszl S; Wu X; Kleine B; Blödorn J; Multhaupt H
    Prog Histochem Cytochem; 1992; 26(1-4):146-58. PubMed ID: 1283015
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.
    Brown DL; Cole BF; Arrick BA
    J Natl Cancer Inst; 1999 Jan; 91(1):90-1. PubMed ID: 9890178
    [No Abstract]   [Full Text] [Related]  

  • 6. Flow cytometric steroid receptor analysis.
    Schutte B; Scheres HM; De Goeij AF; Rousch MJ; Blijham GH; Bosman FT; Ramaekers FC
    Prog Histochem Cytochem; 1992; 26(1-4):68-76. PubMed ID: 1484969
    [No Abstract]   [Full Text] [Related]  

  • 7. [An aggressive subtype of breast carcinoma].
    Dauplat MM; Mishellany F; Delatour M; Penault-Llorca F
    Ann Pathol; 2003 Dec; 23(6):611-2. PubMed ID: 15094600
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between mammaglobin expression and estrogen receptor status in breast tumors.
    Guan XF; Hamedani MK; Adeyinka A; Walker C; Kemp A; Murphy LC; Watson PH; Leygue E
    Endocrine; 2003 Aug; 21(3):245-50. PubMed ID: 14515009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estrogen and progesterone receptors in breast cancer].
    Sonoo H
    Nihon Rinsho; 2000 Apr; 58 Suppl():146-53. PubMed ID: 11025988
    [No Abstract]   [Full Text] [Related]  

  • 10. Diminished ratio of estrogen receptors to progesterone receptors in breast carcinomas of women who have had multiple miscarriages.
    Lehrer S; Levine E; Savoretti P; Cropley J; Dalton J; Song HK; Thung SN; Rabinowitz J; Mandell L
    Mt Sinai J Med; 1992 Jan; 59(1):28-31. PubMed ID: 1734234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic targeting in breast cancer].
    Penault-Llorca F
    Ann Pathol; 2009 Nov; 29 Spec No 1():S71-3. PubMed ID: 19887259
    [No Abstract]   [Full Text] [Related]  

  • 12. pS2 and response to adjuvant hormone therapy in primary breast cancer.
    Spyratos F; Andrieu C; Hacène K; Chambon P; Rio MC
    Br J Cancer; 1994 Feb; 69(2):394-7. PubMed ID: 8297741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen dependence of primary breast cancer--correlation with histologic type and grade.
    Nikolić-Vukosavljević D; Branković-Magić M; Polić D; Vlajić M; Vuletić L; Spuzić I
    Neoplasma; 1992; 39(5):299-304. PubMed ID: 1436244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid hormone receptors and breast cancer.
    Birrell SN
    Med J Aust; 1993 Aug; 159(4):223-4. PubMed ID: 8412886
    [No Abstract]   [Full Text] [Related]  

  • 15. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
    Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
    Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical evaluation of estrogen and progesterone receptors on paraffin sections of breast carcinomas. Practical thoughts based on the study of 368 cases].
    Balaton AJ; Baviera EE; Galet B; Vaury P; Vuong PN
    Arch Anat Cytol Pathol; 1995; 43(1-2):93-100. PubMed ID: 7794034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative enzyme-linked immunosorbent assay for the estrogen-regulated Mr 24,000 protein in human breast tumors: correlation with estrogen and progesterone receptors.
    Adams DJ; McGuire WL
    Cancer Res; 1985 Jun; 45(6):2445-9. PubMed ID: 3886134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 status.
    Wilder RB; Curcio LD; Khanijou RK; Eisner ME; Kakkis JL; Chittenden L; Agustin J; Lizarde J; Mesa AV; Macedo JC; Ravera J; Tokita KM
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):799-803. PubMed ID: 20869583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer.
    Kurebayashi J; Ishida T; Higashi Y; Suemasu K; Nomoto C; Yoshida K
    Jpn J Clin Oncol; 1990 Sep; 20(3):271-80. PubMed ID: 2255103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone receptor status in primary breast cancer--time for a consensus?
    Wishart GC; Gaston M; Poultsidis AA; Purushotham AD
    Eur J Cancer; 2002 Jun; 38(9):1201-3. PubMed ID: 12044506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.